论文部分内容阅读
Background & Aims: Endocannabinoid system (ECS) phys a pivotal role in hepatic diseases.Cannabinoid receptor 2 (CB2) has shown anti-inflammatory and anti-fibrogenic properties by regulating immune cells.However,the relationship between CB1 and inflammatory cells in liver injury is still undefined.